Angioplasty laser to be sold in Europe:
This article was originally published in Clinica
Executive Summary
Spectranetics has CE-marked its latest angioplasty catheter which is designed to create larger channels in blocked coronary arteries than the currently available Vitesse C device. The Colorado Springs-based company submitted a premarketing approval application for the new Vitesse COS device in the US in August.